APDN Applied DNA Sciences Inc

 

Item 3.

If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:

	(a)	[__]	Broker or dealer registered under Section 15 of the Act (15 U.S.C. 78o)
	(b)	[__]	Bank as defined in Section 3(a)(6) of the Act (15 U.S.C. 78c)
	(c)	[__]	Insurance company as defined in Section 3(a)(19) of the Act (15 U.S.C. 78c)
	(d)	[__]	Investment company registered under Section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8)
	(e)	[__]	An investment adviser in accordance with ss.240.13d-1(b)(1)(ii)(E)
	(f)	[__]	An employee benefit plan or endowment fund in accordance with ss.240.13d-1(b)(1)(ii)(F);
	(g)	[__]	A Parent holding company or control person in accordance with ss.240.13d-1(b)(1)(ii)(G);
	(h)	[__]	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813)
	(i)	[__]	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3)
	(j)	[__]	Group, in accordance with ss.240.13d-1(b)(1)(ii)(J).

 

---

Item 4.                    Ownership

The shares of Common Stock reported on this Schedule are indirectly beneficially owned by the Reporting Person.  Dillon Hill Capital, LLC (the “Purchaser”), of which the Reporting Person is the sole member, directly owns $1,500,000 principal amount of secured convertible notes (the “Notes”) that are convertible into 2,777,777 shares of Common Stock of the Issuer.  Until October 13, 2019, the Purchaser has the right to purchase up to an additional $500,000 principal amount of Notes.  Such additional Notes would be convertible into an additional 925,925 shares of Common Stock of the Issuer.  The Notes include a provision limiting conversion of the Notes to the extent that conversion would result in the Reporting Person beneficially owning more than 9.99% of the Issuer’s Common Stock. The Reporting Person may be deemed to have sole voting and dispositive power over shares held by Dillon Hill Capital LLC.

The percentage beneficial ownership reported in Item 11 of the cover pages to this Schedule was calculated based on 37,885,157 shares of Common Stock outstanding as of April 30, 2019, as reported in the Issuer’s quarterly report on Form 10-Q for the period ended March 31, 2019.

---